Header Logo

Connection

Matthew Meriggioli to Receptors, Tumor Necrosis Factor

Back to Details
This is a "connection" page, showing publications Matthew Meriggioli has written about Receptors, Tumor Necrosis Factor.
Matthew Meriggioli
Connection Strength
0.122
Receptors, Tumor Necrosis Factor
  1. Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment. J Autoimmun. 2005 May; 24(3):261-8.
    View in: PubMed
    Score: 0.061
  2. Etanercept treatment in corticosteroid-dependent myasthenia gravis. Neurology. 2004 Dec 28; 63(12):2390-2.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.